What is the sensibility of using quick Sepsis-related Organ Failure Assessment (qSOFA) in clinical practice?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

qSOFA Sensitivity for Sepsis Detection

qSOFA has poor sensitivity (28-42%) for early sepsis detection and should not be used as a standalone screening tool, but rather combined with other clinical parameters or reserved for risk stratification in already-identified septic patients. 1

Performance Characteristics of qSOFA

Sensitivity Limitations

  • qSOFA demonstrates critically low sensitivity ranging from 16-33% when measured at triage (tqSOFA) for identifying patients who will develop severe sepsis or septic shock 2, 3
  • Even maximum qSOFA measured during ED treatment only achieves 67-69% sensitivity, which remains inferior to other screening tools 3, 4
  • The prehospital qSOFA ≥2 shows only 16.3% sensitivity (95% CI 6.8-30.7%) for severe sepsis/septic shock identification 2

Comparative Performance

  • NEWS2 significantly outperforms qSOFA with sensitivity of 84-86% compared to qSOFA's 28-42%, making it the preferred initial screening tool per NICE 2024 guidelines 1
  • Traditional SIRS criteria demonstrate 82-86% sensitivity, substantially higher than qSOFA 1, 3
  • Initial serum lactate >3 mmol/L shows 65% sensitivity, still superior to triage qSOFA 3

Why qSOFA Has Poor Sensitivity

Design Limitations

  • qSOFA was designed for risk stratification, not screening - it identifies high-risk patients who already have sepsis rather than detecting early sepsis 1
  • The dynamic nature of sepsis means patients often don't meet qSOFA thresholds (SBP ≤100 mmHg, RR ≥22/min, altered mental status) until organ dysfunction is advanced 2
  • Approximately two-thirds of severe sepsis/septic shock patients only meet qSOFA criteria later during their ED stay, missing the critical early intervention window 2

Guideline Recommendations

Current Clinical Guidance

  • The Surviving Sepsis Campaign 2021 explicitly recommends against using qSOFA as a single screening tool due to insufficient sensitivity 4
  • The American College of Emergency Physicians recommends qSOFA ≥2 only to identify high-risk patients requiring immediate full SOFA assessment, not for initial screening 5
  • NICE 2024 guidelines specifically recommend NEWS2 for initial assessment and repeated monitoring of suspected sepsis patients 1

Appropriate Use of qSOFA

  • qSOFA is best utilized for prognostication - patients with qSOFA ≥2 have >10% mortality risk and increased likelihood of ICU admission ≥3 days 6, 5
  • High qSOFA/SOFA scores identify patients at greatest risk of death who may benefit most from aggressive interventions like corticosteroids 7

Strategies to Improve Sensitivity

Combination Approaches

  • Adding clinical parameters to qSOFA increases sensitivity to 58.1% - incorporating pulse >100, nursing home residence, age >50, or reported fever improves detection but reduces specificity to 78% 2
  • Combining qSOFA with Q-CRT achieves 83.3% sensitivity and 81.4% specificity (AUC 0.821), exceeding 80% for both metrics 8
  • Combining qSOFA with lactate levels achieves 87.5% sensitivity and 81.4% specificity (AUC 0.844), representing optimal performance 8
  • Using both prehospital and ED qSOFA (combined qSOFA ≥3) improves sensitivity to 67% compared to ED qSOFA alone at 55%, identifying an additional 12% of sepsis cases 4

Lactate-Enhanced qSOFA (LqSOFA)

  • LqSOFA demonstrates 61% sensitivity and 81% specificity for predicting in-hospital mortality with an AUC of 0.807 and odds ratio of 7.43 9
  • This represents meaningful improvement over qSOFA alone while maintaining good specificity 9

Clinical Pitfalls to Avoid

Common Errors

  • Never rely on qSOFA alone for sepsis screening - this will miss 58-84% of sepsis cases at presentation 1, 2, 3
  • Don't wait for qSOFA ≥2 before initiating sepsis workup in patients with suspected infection and other concerning features 1
  • Recognize that normal blood pressure and respiratory rate don't exclude early sepsis - these parameters deteriorate late in the disease course 2

Recommended Approach

  • Use NEWS2 as the primary screening tool with scores ≥7 indicating high risk requiring evaluation every 30 minutes 1
  • Reserve qSOFA for risk stratification once sepsis is suspected, not for initial detection 1, 5
  • Combine qSOFA with lactate measurement or Q-CRT when available to achieve >80% sensitivity and specificity 8
  • Calculate full SOFA score (≥2 point increase confirms sepsis) when qSOFA ≥2 or other high-risk features present 5

References

Guideline

Early Sepsis Detection and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Sepsis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Sepsis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lactate-enhanced-qSOFA (LqSOFA) score as a predictor of in-hospital mortality in patients with sepsis: systematic review and meta-analysis.

European journal of trauma and emergency surgery : official publication of the European Trauma Society, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.